SCHEMBL30461597

SCHEMBL30461597

c1cncc(-c2cc3ccncc3o2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.47
CYP3A4 P08684 5/20 0.47
CYP1A2 P05177 4/20 0.47
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 5/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
PPARG P37231 1/20 0.46
CYP1A1 P04798 1/20 0.46
PRKDC P78527 1/20 0.46
CYP1B1 Q16678 1/20 0.46
PGR P06401 1/20 0.46
CYP19A1 P11511 3/20 0.45
CYP2C19 P33261 5/20 0.45
CYP2D6 P10635 4/20 0.45
CYP2C9 P11712 4/20 0.45
CYP2E1 P05181 3/20 0.45
CYP2B6 P20813 3/20 0.45
HSD17B10 Q99714 3/20 0.45
NPC1 O15118 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2960606 0.86 MAOB (0.54) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL29993564 0.86 MAOB (0.54) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL15867533 0.86 CYP19A1 (0.51) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL21735349 0.81 SHBG (0.61) CYP3A4CYP1A2KDM4EKMT2ACYP1A1
SCHEMBL21295874 0.80 CYP2A6 (0.42) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL21735530 0.79 CYP19A1 (0.62) CYP3A4CYP1A2ALDH1A1KDM4EKMT2A
SCHEMBL21295722 0.76 CYP2A6 (0.42) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL25218648 0.74 KDM4E (0.42) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL30461684 0.74 KDM4E (0.42) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL21476417 0.73 MAOB (0.50) CYP2A6ALDH1A1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4444721-A1 COMPOUNDS FOR USE IN TREATING NEUROLOGICAL DISORDERS Prothena Biosciences Limited (IE) 2024-10-16 EP disclosed
WO-2023107722-A1 COMPOUNDS FOR USE IN TREATING NEUROLOGICAL DISORDERS PROTHENA BIOSCIENCES LIMITED (IE) 2023-06-15 WO disclosed